Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADOPA: ACTH Stimulation in Adrenal Venous Sampling for Primary Aldosteronism
NCT04461535Completed
- Sponsor
- Chongqing Medical University
- Start
- Jul 2020
- Primary completion
- Feb 2023
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tetracosactide hexaacetate in primary aldosteronism (PA) (2 arms), sponsored by Chongqing Medical University. Primary endpoint: Proportion of surgically treated patients with complete biochemical remission at 12 months. Started Jul 2020; status: completed.
02
Drugs
tetracosactide hexaacetate
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT04461535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04461535.